These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11559975)

  • 1. Closing in on cancer.
    O'Keefe B
    Fortune; 2001 Sep; 144(5):222. PubMed ID: 11559975
    [No Abstract]   [Full Text] [Related]  

  • 2. The difficulties industry is facing with investigators.
    Blackledge GR
    Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 4. Experts predict bleak post-genomic era for drug R&D.
    Birmingham K
    Nat Med; 2001 Mar; 7(3):262. PubMed ID: 11231601
    [No Abstract]   [Full Text] [Related]  

  • 5. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 6. Amgen becomes a stronger cancer player.
    Kling J
    Nat Biotechnol; 2006 Feb; 24(2):119. PubMed ID: 16465140
    [No Abstract]   [Full Text] [Related]  

  • 7. Putting pharmacogenetics into practice.
    Hopkins MM; Ibarreta D; Gaisser S; Enzing CM; Ryan J; Martin PA; Lewis G; Detmar S; van den Akker-van Marle ME; Hedgecoe AM; Nightingale P; Dreiling M; Hartig KJ; Vullings W; Forde T
    Nat Biotechnol; 2006 Apr; 24(4):403-10. PubMed ID: 16601719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 9. Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies?
    Gallant GJ
    Future Med Chem; 2012 Jan; 4(1):13-7. PubMed ID: 22168161
    [No Abstract]   [Full Text] [Related]  

  • 10. Business barriers slowing the pace of cancer immunotherapy research and development.
    Tuma RS
    J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521
    [No Abstract]   [Full Text] [Related]  

  • 11. Investing in oncology biotech stocks.
    Feuerstein A
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
    [No Abstract]   [Full Text] [Related]  

  • 12. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 14. This Dutchman is flying.
    Watson N
    Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic cancer vaccines on trial.
    Reichert JM; Paquette C
    Nat Biotechnol; 2002 Jul; 20(7):659-63. PubMed ID: 12089545
    [No Abstract]   [Full Text] [Related]  

  • 16. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 17. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

  • 18. BIO and biogenerics.
    Feldbaum CB
    Nat Biotechnol; 2005 Jan; 23(1):17; discussion 17. PubMed ID: 15637607
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemispherx: 300 patents, 20 staff.
    Chahine K
    Nat Biotechnol; 1997 Jul; 15(7):612-3. PubMed ID: 9219255
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiinfective biotechs face partnering gap.
    Sheridan C
    Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.